Hygea and Admera Health, a CLIA Certified/CAP Accredited Laboratory, Announce Formal Partnership
May 26, 2020 09:13 ET
|
Admera Health, LLC
SAN FRANCISCO and SOUTH PLAINFIELD, N.J., May 26, 2020 (GLOBE NEWSWIRE) -- Hygea Precision Medicine (Hygea), a company focused on developing a precision medicine software system for healthcare...
Admera Health Genetic Tests are Now In-Network with CareFirst BlueCross BlueShield, Maryland, Washington D.C, and Northern Virginia
December 11, 2018 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Admera Health (www.admerahealth.com), an advanced molecular diagnostics company, announced today that its genetic testing services are now...
Admera Health Announces Availability of Psychiatric Specific Report, PGxPsych™, for its PGxOne™ Plus Pharmacogenomics Test
June 26, 2018 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., June 26, 2018 (GLOBE NEWSWIRE) -- Today, Admera Health (www.admerahealth.com), announced the availability of a psychiatric specific report for its PGxOne™ Plus...
Admera Health Expands Asian Footprint with Three Strategic Partnerships
September 12, 2017 11:05 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Today, Admera Health announced agreements expanding Admera’s portfolio of molecular diagnostics to Asia, including but not limited to...
Columbia University Medical Center’s Center for Biomedical Informatics Collaborates with Admera Health in a Clinical Study, Evaluating Pharmacogenetics in Psychiatric Medications
July 25, 2017 19:00 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., July 25, 2017 (GLOBE NEWSWIRE) -- Admera Health, an advanced molecular diagnostic laboratory, has been selected by Columbia University Medical Center’s Center for Biomedical...
University of Rochester School of Medicine and Dentistry Collaborate with Admera Health in a Clinical Study, Evaluating Pharmacogenomics in Acute Surgical Pain Management
May 09, 2017 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J. and ROCHESTER, N.Y., May 09, 2017 (GLOBE NEWSWIRE) -- Today, the University of Rochester School of Medicine and Dentistry and Admera Health announced that enrollment had...
Admera Health Reaches Yet Another Significant Milestone, by Achieving New CLEP Approval for PGxOne™ Plus, a 50 Gene Pharmacogenomics Test
March 16, 2017 10:31 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., March 16, 2017 (GLOBE NEWSWIRE) -- Advanced Molecular Diagnostics company, Admera Health, (www.admerahealth.com) announced today that its PGxOne™ Plus has received New...
Admera Health Reaches Significant Major Milestone in Achieving New York Department of CLEP Approval for PGxOne™ Plus, a 25 Gene Pharmacogenomics Test
November 01, 2016 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Molecular Diagnostics company, Admera Health, (www.admerahealth.com) announced today that it received New York State Clinical Laboratory...
Admera Health Expands its Next Generations Sequencing Based Pharmacogenomics Test with Update to PGxOne™ Plus
September 21, 2016 09:00 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Sept. 21, 2016 (GLOBE NEWSWIRE) -- Molecular Diagnostics company, Admera Health, (www.admerahealth.com) today announced that its PGxOne™ Plus pharmacogenomics test has been...